Recombinant Human Anti-IL23 x Human Anti-IL6 Bispecific Antibody (scFv-IgG) (BSSG-H343)

Recombinant Anti-IL23 x Anti-IL6 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-IL23 antibody variable domain are respectively connected to the N terminus of the anti-IL6 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Inflammatory diseases therapy.

Datasheet INQUIRY

Specifications

Targets

IL23 & IL6

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inflammatory diseases

Targets

Target 1

IL23

Gene ID

51561

UniProt ID

Q9NPF7

Alternative Names

P19; SGRF; IL-23; IL-23A; IL23P19; Interleukin-23; IL23; interleukin 23 subunit alpha

Target 2

IL6

Gene ID

3569

UniProt ID

P05231

Alternative Names

CDF; HGF; HSF; BSF2; IL-6; BSF-2; IFNB2; IFN-beta-2; interleukin 6; IL6

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-IL23 x Human Anti-IL6 Bispecific Antibody (scFv-IgG) (BSSG-H343). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-IL23 x Human Anti-IL6 Bispecific Antibody (scFv-IgG) (CAT#: BSSG-H343)

Specifications

Targets

Customer Reviews and Q&As